Quantum Biopharma Ltd. QNTM
3.85
(0.15)
(3.75%)
as of 25 Sep
- Market cap
- $30.9M
- P/E
- 0.0×
Follow QNTM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
1.19 | 0.63 | 0.79 | 1.39 | |
Current Ratio |
1.20 | 0.63 | 1.07 | 1.41 | |
Net Debt/EBITDA |
4.50 | 3.53 | 2.04 | 1.39 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.55 | 0.12 | 0.10 | 0.32 | |
Capex/Depreciation |
(10.33) | (22.71) | (0.83) | 5.98 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.30 | 0.30 | 0.40 | 0.33 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.27) | (0.37) | (0.09) | (0.45) | |
Capex per Share |
(0.20) | (0.64) | (0.03) | 0.23 | |
Free Cash Flow per Share |
(0.47) | (1.02) | (0.13) | (0.22) | |
Cash per Share |
1.47 | 2.24 | 1.39 | 1.65 | |
Shareholders Equity per Share |
0.92 | (0.32) | 1.55 | 1.97 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.92 | (0.32) | 1.55 | 1.97 | |
Free Cash Flow |
(3.12) | (4.56) | (0.41) | (0.85) | |
Working Capital |
1.66 | (5.98) | 0.42 | 2.70 | |
Capital Expenditures |
(1.33) | (2.89) | (0.11) | 0.87 | |
Net Current Asset Value |
1.66 | (5.98) | 0.42 | 2.70 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
1.57 | 1.81 | 2.02 | 5.01 | |
Average Payables |
3.29 | 2.97 | 4.27 | 3.70 | |
Average Inventory |
0.06 | 0.07 | 0.08 | 0.39 | |
Average Assets |
14.84 | 14.90 | 14.14 | 16.59 | |
Average Common Equity |
4.07 | 1.55 | 7.77 | 11.43 |
Columns are period end dates